β-Lactams Enhance Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus Bacteremia Compared to Vancomycin Alone

Novel Combinations of Vancomycin plus Ceftaroline or Oxacillin against Methicillin-Resistant Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA

(2013) B. J. Werth et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Ampicillin Plus Ceftriaxone Is as Effective as Ampicillin Plus Gentamicin for TreatingEnterococcus faecalisInfective Endocarditis

(2013) Nuria Fernández-Hidalgo et al.   CLINICAL INFECTIOUS DISEASES

Multicenter Evaluation of the Clinical Outcomes of Daptomycin with and without Concomitant β-Lactams in Patients with Staphylococcus aureus Bacteremia and Mild to Moderate Renal Impairment

(2012) Pamela A. Moise et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synergy between Vancomycin and Nafcillin against Staphylococcus aureus in an In Vitro Pharmacokinetic/Pharmacodynamic Model

(2012) Steven N. Leonard   PLoS One

Vancomycin AUC24/MIC Ratio in Patients with Complicated Bacteremia and Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus and Its Association with Attributable Mortality during Hospitalization

(2011) Jack Brown et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroPharmacodynamics of Vancomycin and Cefazolin Alone and in Combination against Methicillin-Resistant Staphylococcus aureus

(2011) Mao Hagihara et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Use of Antistaphylococcal  -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding

(2011) A. Dhand et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia

(2011) C. J. Walraven et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Detection of Staphylococcus aureus Isolates with Heterogeneous Intermediate-Level Resistance to Vancomycin in the United States

(2011) S. S. Richter et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Predictors of Relapse of Methicillin-Resistant Staphylococcus aureus Bacteremia after Treatment with Vancomycin

(2011) K. J. Welsh et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Daptomycin-Oxacillin Combinations in Treatment of Experimental Endocarditis Caused by Daptomycin-Nonsusceptible Strains of Methicillin-Resistant Staphylococcus aureus with Evolving Oxacillin Susceptibility (the "Seesaw Effect")

(2010) S.-J. Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Factors Influencing Time to Vancomycin‐Induced Clearance of Nonendocarditis Methicillin‐ResistantStaphylococcus aureusBacteremia: Role of Platelet Microbicidal Protein Killing andagrGenotypes

(2009) Pamela A. Moise et al.   JOURNAL OF INFECTIOUS DISEASES